Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classificação em ações #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Preço da ação
$0.12164306
Última sincronização: 2024-11-11
Valor de mercado
$38.53M
Variação (1 dia)
-4.14%
Variação (1 ano)
0.00%
País
AU
Negociar PharmAust Limited (PAA)

Categoria

EPS de PharmAust Limited (PAA)
EPS em June 2024 TTM: $-0.01
De acordo com os últimos relatórios financeiros e o preço das ações da PharmAust Limited, o EPS atual da empresa (TTM) é $-0.01. No final de 2023, a empresa teve um EPS de $-0.01, uma diminuição em relação a ao EPS de 2022, que foi de $0.00.
Histórico de EPS da PharmAust Limited de 2001 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-0.01 -41.50%
2024 $-0.02 26.36%
2023 $-0.01 248.65%
2022 0.00 19.35%
2021 0.00 -3.13%
2020 0.00 -36.00%
2019 $-0.01 -60.63%
2018 $-0.01 53.01%
2017 $-0.01 -73.82%
2016 $-0.03 61.73%
2015 $-0.02 4.81%
2014 $-0.02 23.03%
2013 $-0.02 -90.70%
2012 $-0.16 -57.64%
2011 $-0.39 1,413.73%
2010 $-0.03 142.86%
2009 $-0.01 -97.72%
2008 $-0.46 -48.36%
2007 $-0.89 96.82%
2006 $-0.45 -40.46%
2005 $-0.76 -18.86%
2004 $-0.94 -11.50%
2003 $-1.06 -45.34%
2002 $-1.94 47.75%
2001 $-1.31 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$17.32 -148,134.19%
US
$27.74 -237,194.02%
NL
$2.98 -25,570.09%
AU
$-7.98 68,105.13%
US
- -
CH